Zai Lab Ltd cotiza a 24.59 USD y tiene una capitalización bursátil de $2.8B. En los últimos 12 meses ha facturado $450M con un margen de flujo de caja libre del -34.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhi…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.46 | $-0.46 | $-0.46 |
| Estimado | $-0.56 | $-0.68 | $-0.53 | $-0.42 |
| Sorpresa | — | +32.4% | +13.2% | -9.5% |
| Métrica | ZLAB | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 58.6% | 57.0% | +1.6% |
| Operating Margin | -49.9% | -38.6% | -11.2% |
| Net Margin | -38.1% | -33.6% | -4.6% |
| FCF Margin | -34.5% | -13.9% | -20.7% |
| ROE | -24.5% | -40.4% | +15.9% |
| ROA | -15.0% | -32.0% | +17.0% |
| Current Ratio | 2.45 | 2.84 | -0.39 |
| Debt / Equity | — | 0.28 | — |